Aug 7, 2025, 01:00 AM by User Not Found

Bio-IT World | Russia plans to significantly expand its national database of genetic information by 2030 according to a recent decree approved by the Russian government. As part of the plans, the volume of the already existing database will be increased by 35 times and reach 35 petabytes by 2030.

Aug 6, 2025, 09:11 AM by

Aug 6, 2025, 09:11 AM by

Supreme Group Acquires Pivot Design, Marking a Significant Expansion in Pharma and Rare Disease

Aug 6, 2025, 09:11 AM by

VieCure adds Summit Cancer Centers to community oncology care network.

Aug 6, 2025, 09:11 AM by

Alfa Chemistry has launched a new portfolio of food surfactants designed to improve stability, texture, and processing efficiency in modern food manufacturing, supporting clean-label and plant-based formulation trends.

Aug 6, 2025, 01:00 AM by User Not Found

Bio-IT World | The Alzheimer's Association International Conference was held last week in Toronto and researchers and companies gathered to present their progress in the fight to diagnose and treat Alzheimer’s disease. Among the timely new developments: new products from Quanterix; pre-clinical data from AltPep, OncoC4, and NKGen Biotech; pipeline updates from Eisai, Biogen, and Roche; and more.

Aug 5, 2025, 09:17 AM by

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced a research collaboration with Syntekabio, Inc., a leading artificial intelligence (AI)-driven drug discovery company, to identify additional disease targets and optimize the therapeutic profile of DA-1241, MetaVia’s novel oral G-Protein-Coupled Receptor 119 (GPR119) agonist.

Aug 5, 2025, 09:17 AM by

• Investment in premises on Cambridge Technopark reflects significant milestone in the Company’s growth • Relocation increases logistics and R&D capacity, enabling faster customization and turnaround, strengthening order fulfilment to better support customers in their research and development efforts

Aug 5, 2025, 09:17 AM by

Former Covera Health CTO to lead technology and product strategy at Advarra, driving innovation in clinical research

Aug 5, 2025, 09:17 AM by

New research from the COPD Foundation and Phreesia shows patients with chronic obstructive pulmonary disease (COPD) face significant challenges, but conversations with healthcare providers can play a critical role in helping patients understand their condition, set realistic goals, ease symptom burden and improve their quality of life.

Aug 5, 2025, 09:17 AM by

Aug 5, 2025, 09:17 AM by

InSysBio announces Immune Response Template (IRT) which was previously available under a license model now is completely free to use. IRT represents a QSP platform of immune system, simultaneously, being a tool for development of models related to immune system.

Aug 5, 2025, 09:17 AM by

I wanted to share that Software-as-a-Service (SaaS) security leader, AppOmni today announced new innovations to combat rising AI and SaaS risks for healthcare companies: https://appomni.com/press-releases/saas-ai-security-innovation Please let me know if you’d like to speak with them for more about the benefits for healthcare, get a product image, or if I can provide anything further. The rapid adoption of AI has introduced a new and complex attack surface that healthcare cybersecurity teams must manage. AI is an active participant in the SaaS environment; whether embedded in SaaS platforms (such as M365 or Google Workspace) or acting as agents, AI tools constantly access and process sensitive data across the SaaS estate. Healthcare organizations need the ability to identify unsanctioned or shadow AI and SaaS usage, as well as practical strategies to control and monitor AI usage. AppOmni is defining the future of SaaS and AI security by arming organizations of all sizes with the end-to-end controls needed for safe usage of these applications, helping them identify critical risks, protect sensitive data, detect abnormal behavior, and respond to evolving threats. The new features help healthcare understand their risk exposure to AI and implement controls to secure them by identifying both sanctioned and unsanctioned/ shadow AI apps, including AI embedded within SaaS applications. It’s also adding support for 30 new AI and SaaS applications, including ChatGPT Enterprise, Claude, OpenAI, and Anthropic, Cisco Umbrella, Cisco Secure Access, and Gong. And it’s giving healthcare organizations a free 90-day trial of its new AppOmni Foundations package – a SaaS security starter solution for organizations that need to discover shadow SaaS and AI, app users and permission, and detect threats and anomalous activities.

Aug 5, 2025, 01:00 AM by User Not Found

Bio-IT World | A new biotech company launched last month with a novel approach to protein discovery that could transform how researchers identify biomarkers and develop treatments for cardiovascular disease, cancer, and neurodegenerative conditions. XProteome, founded by Michigan State University researcher Morteza Mahmoudi, has developed an integrated platform that combines nanomedicine, artificial intelligence, and causality analysis to pinpoint disease-causing proteins with unprecedented precision.

Aug 4, 2025, 08:46 AM by

iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions

Jul 31, 2025, 09:29 AM by

Clinisys announces the acquisition of Orchard Software from Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses. The acquisition brings together two leaders in the LIS market and reaffirms Clinisys’s continued commitment to provide the laboratory informatics marketplace with cutting edge software advancements.

Jul 31, 2025, 09:29 AM by

Jul 31, 2025, 09:29 AM by

Jul 31, 2025, 09:29 AM by

MAGENTIQ EYE Secures Series A Investment Led by aMoon to Drive the Future of AI-Powered Gastroenterology

Jul 31, 2025, 01:00 AM by User Not Found

Bio-IT World | The Longitude Prize on ALS, presented at this year’s Bio-IT World Conference & Expo, has launched to incentivize and reward cutting edge AI-based approaches to transform drug discovery for the treatment of ALS (amyotrophic lateral sclerosis); UK Biobank completed the world’s largest whole body imaging project; and more.